Avoid injecting too close to the knee joint or groin
Early in regenerative medicine, they seemed promising and were used in many ways: intravenous, intra-articular, intravaginal, and intralesional
Each dose increase gives your appetite-regulating pathways time to adjust to stronger GIP and GLP-1 receptor signaling
For a comprehensive review of the anti-obesity effects of GLP-1RAs, which is beyond the purpose of this article, see ref
since the 1970s
The structured escalation pathway: Weeks 14: 0.25 mg (initiation dose) From week 5: 0.5 mg (first maintenance dose) If needed, after 4 weeks: 1 mg (maintenance dose) If needed, after 4 weeks: 2 mg (maximum licensed dose) Clinical decisions regarding dose escalation should be individualised, taking into account HbA1c levels, tolerability, body weight changes, and the presence of other cardiovascular risk factors